Standout Papers

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation 2011 2026 2016 2021 1.5k
  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation (2011)
    Bonnie W. Ramsey, Jane C. Davies et al. New England Journal of Medicine
  2. Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation (2013)
    Jane C. Davies, Claire Wainwright et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

1 by Nobel laureates 19 from Science/Nature 97 standout
Sub-graph 1 of 16

Citing Papers

Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Future therapies for cystic fibrosis
2023 Standout
93 intermediate papers

Works of Karl Yen being referenced

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
2013 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Karl Yen 2107 576 263 304 21 2.8k
Xiaohong Huang 1675 251 236 166 26 2.4k
Koustubh Ranade 643 596 339 321 59 3.2k
John Deighton 394 450 259 942 29 2.0k
Sandra L. Dunnette 726 1351 106 493 27 2.2k
Joëlle Simony-Lafontaine 1094 1839 145 661 25 3.4k
ANTONIO M. VIGNOLA 1649 2183 55 494 12 3.0k
Lutz Wollin 2433 1047 72 68 51 3.5k
Geoffrey Gilmartin 1861 2048 57 432 18 2.8k
Dale K. Kobayashi 1507 555 59 385 31 4.3k
Sam Lim 1941 2662 88 426 33 4.1k

All Works

Loading papers...

Rankless by CCL
2026